CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease - Concepedia

Concepedia

Publication | Open Access

CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease

DOI Full Paper Access

32

Citations

36

References

2022

Year

Alan J. Lerner, Steven E. Arnold, Erin Maxfield, Aaron Koenig, Maria E. Toth, Brooke Fortin, Natalia Mast, Bianca A. Trombetta, John A. Denker, Andrew A. Pieper,

Alzheimer s Research & Therapy

References

	Year	Citations

Page 1